|
Reference | Diagnosis | Gestational age at transplant | Immunosuppression | Outcome |
|
Morris et al. [20] | Acute liver failure from drug induced liver injury | 27 weeks | Prednisone and cyclosporine | Successful deceased donor liver transplant and neonatal death |
Laifer et al. [6, 17] | Fulminant Hepatitis B | 26 weeks | Prednisone and cyclosporine | Delivery by c section at 28 weeks and neonatal death |
Fair et al. [18] | 21 y/o woman with acute liver failure from Hepatitis B | 22 weeks gestation | Steroids, OKT3, and cyclosporine | Deceased donor liver transplant with primary malfunction, followed by successful retransplantation on postop day 2. C section at 30 weeks. Fetus survived and healthy. Fetus had IUGR and severe oligohydramnios |
Moreno et al. [14] | 32 y/o female with cryptogenic acute liver failure | 27 weeks | Methylprednisolone, cyclosporine, and azathioprine | Successful deceased donor liver transplantation Fetus survived. C-section at 39 weeks. Infant healthy at 11 months |
Hamilton et al. [19] | 20 y/o woman with acute liver failure from Hepatitis B | 18 weeks | n/a | Successful deceased donor liver transplantation. Fetal death on posttransplant day 5 |
Finlay et al. [22] | Acute liver failure | 17 weeks | n/a | Successful deceased donor liver transplantation. Fetal death at 22 weeks |
Lo et al. [15] | 25 y/o with cryptogenic acute liver failure | 26 weeks | n/a | Successful left lobe living donor liver transplantation. Spontaneous abortion posttransplant day 2 |
Catnach et al. [21] | 27 y/o woman with end stage autoimmune hepatitis | 20 weeks | Cyclosporine, prednisolone, and azathioprine | Successful deceased donor liver transplantation. Successful delivery at 28 weeks. Recipient developed CMV infection |
Laifer et al. [6, 17] | 30 y/o female decompensated cirrhosis from autoimmune liver disease | 23 weeks | Tacrolimus and prednisone | Fetal death posttransplant day 6 |
Eguchi et al. [7] | 28 y/o woman with cryptogenic acute liver failure | 15 weeks | Prednisone and tacrolimus | Successful adult living donor liver transplant. Artificial abortion posttransplant day 31. Recipient developed CMV infection |
Kato et al. [8] | 31 y/o female with cryptogenic acute liver failure | 14 weeks | Methylprednisolone, tacrolimus, and 2 days of mycophenolate mofetil | Left lateral segment adult to adult living donor liver transplantation. Spontaneous abortion immediately after transplant |
Jarufe et al. [9] | 35 y/o female with cryptogenic acute liver failure | 22 weeks | Prednisone and tacrolimus | Successful deceased donor liver transplantation. Delivery at 27 weeks of gestation. Normal psychomotor development at 1-year followup |
Jankovic et al. [10] | 26 y/o female with cryptogenic familial biliary cirrhosis | 13.5 weeks | Tacrolimus, azathioprine, and prednisolone | Successful liver transplantation. Vaginal delivery at 36 weeks |
Anders et al. [16] | 18 y/o female with cryptogenic acute liver failure | 20 weeks | n/a | Successful liver transplantation. Fetal death 48 hours after transplantation |
Sequeira et al. [11] | 36 y/o female with drug induced acute liver failure due to propylthiouracil | 18 weeks | Tacrolimus, cyclosporine, and prednisolone | Successful liver transplantation. Elective cesarean section at 37 weeks. Child had IUGR, oligohydramnios, decreased cerebral volume, ventriculomegaly, microcephaly, seizures, and delayed developmental milestones |
Current case | 29 y/o female with cryptogenic acute liver failure | 11 weeks | Tacrolimus and prednisone | Successful deceased donor liver transplantation. Healthy female fetus delivered at 30 weeks. Normal psychomotor development at 4-year followup |
|